Cytotoxic T cells are silenced to induce disease tolerance in human malaria

Diana Munoz Sandoval,Florian A Bach,Alasdair Ivens,Adam C Harding,Natasha L Smith,Michalina Mazurczyk,Yrene Themistocleous,Nick J Edwards,Sarah E Silk,Jordan R Barrett,Graeme JM Cowan,Giorgio Napolitani,Nick J Savill,Simon J Draper,Angela M Minassian,Wiebke Nahrendorf,Philip J Spence

DOI: https://doi.org/10.1101/2021.08.19.21262298

2024-10-04

Abstract:Immunity to severe malaria is acquired quickly, operates independently of pathogen load and represents a highly effective form of disease tolerance. The mechanism that underpins tolerance remains unknown. We developed a human re-challenge model of falciparum malaria in which healthy adult volunteers were infected three times over a 12 month period to track the development of disease tolerance in real-time. We found that parasitemia triggered a hardwired emergency host response that led to systemic inflammation, pyrexia and hallmark symptoms of clinical malaria across the first three infections of life. In contrast, a single infection was sufficient to reprogramme T cell activation and reduce the number and diversity of effector cells upon re-challenge. Crucially, this did not silence stem-like memory cells but instead prevented the generation of cytotoxic effectors associated with autoinflammatory disease. Tolerised hosts were thus able to prevent collateral tissue damage in the absence of anti-parasite immunity.